The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKeywords Studios Plc Regulatory News (KWS)

Share Price Information for Keywords Studios Plc (KWS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,139.00
Bid: 1,141.00
Ask: 1,144.00
Change: 3.00 (0.26%)
Spread: 3.00 (0.263%)
Open: 1,131.00
High: 1,164.00
Low: 1,131.00
Prev. Close: 1,136.00
KWS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Shares

12 Jun 2023 07:16

RNS Number : 3808C
Keywords Studios PLC
12 June 2023
 

 12 June 2023

Keywords Studios plc

("Keywords Studios", the "Company")

Issue of Shares

Keywords Studios, the international technical and creative services provider to the global video games and entertainment industries, today announces the issuance of 191,722 new ordinary shares to the vendors of Tantalus Media Pty Ltd ("Tantalus") in respect of the share element of contingent consideration due based on the performance of Tantalus over the 24-month period post-completion.

Application has been made to the London Stock Exchange for the admission of these 191,722 new ordinary shares to trading on AIM. Admission of the new shares is expected to take place at 8:00am on 15 June 2023.

The Company's total issued share capital following admission will consist of 79,084,617 ordinary shares of one pence each with one voting right per share. There are 97,372 Ordinary Shares in the Company's Employee Benefit Trust ("EBT"), and the EBT has waived its right to exercise its voting rights and to receive dividends in respect of these Ordinary Shares.

Therefore, the number of Ordinary shares with voting rights is 78,987,245. This figure may be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company following admission.

For further information, please contact:

Investor Contacts:

 

Media Contacts:

Keywords Studios

Giles Blackham

Director of Investor Relations

+44 7714 134 681

gblackham@keywordsstudios.com

 

MHP Group

Katie Hunt / Eleni Menikou / Charles Hirst

+44 20 3128 8794

keywords@mhpgroup.com

 

Numis Securities

Nominated Adviser & Broker

Stuart Skinner / Will Baunton

+44 20 7260 1000

 

 

 

About Keywords Studios (www.keywordsstudios.com)

Keywords Studios is an international technical and creative services provider to the global video games and entertainment industries. Established in 1998, and now with over 70 facilities in 26 countries strategically located in Asia, Australia, the Americas, and Europe, it provides services across the entire content development life cycle through its Create, Globalize and Engage service lines to a large blue-chip client base across the globe.

Keywords Studios has a strong market position, providing services to 24 of the top 25 most prominent games companies. Across the games and entertainment industry, clients include Activision Blizzard, Bandai Namco, Bethesda, Electronic Arts, Epic Games, Konami, Microsoft, Netflix, Riot Games, Square Enix, Supercell, TakeTwo, Tencent and Ubisoft. Recent titles worked on include Elden Ring, Star Wars Jedi: Fallen Order, Valorant, League of Legends, Fortnite, Clash Royale and Doom Eternal. Keywords Studios is listed on AIM, the London Stock Exchange regulated market (KWS.L).

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEQLLBFXQLFBBZ
Date   Source Headline
19th Apr 20243:59 pmRNSPublication of Annual Report and Accounts
10th Apr 20247:46 amRNSIssue of Shares
2nd Apr 20247:00 amRNSTotal Voting Rights
22nd Mar 20242:15 pmRNSHolding(s) in Company
14th Mar 20247:00 amRNSIssue of Shares
13th Mar 20247:00 amRNSFinal Results
6th Mar 20243:51 pmRNSDirector/PDMR Shareholding
1st Mar 20247:00 amRNSTotal Voting Rights
6th Feb 20247:00 amRNSDirector/PDMR Shareholding
1st Feb 20247:00 amRNSTotal Voting Rights
25th Jan 20247:00 amRNSFull Year Trading Update
9th Jan 20247:00 amRNSAppointment of Joint Corporate Broker
2nd Jan 20244:14 pmRNSTotal Voting Rights
2nd Jan 20249:45 amRNSIssue of Shares
18th Dec 20237:00 amRNSAcquisition
6th Dec 20234:26 pmRNSIssue of Shares
1st Dec 20237:00 amRNSTotal Voting Rights
16th Nov 20239:37 amRNSIssue of Shares
13th Nov 20237:00 amRNSBlock listing return
8th Nov 20237:00 amRNSDirector/PDMR Shareholding
1st Nov 20235:11 pmRNSTotal Voting Rights
26th Oct 20231:57 pmRNSHolding(s) in Company
24th Oct 20232:54 pmRNSHolding(s) in Company
18th Oct 20237:00 amRNSDirector Share Purchase
2nd Oct 20231:34 pmRNSTotal Voting Rights
26th Sep 20233:35 pmRNSHolding(s) in Company
20th Sep 20232:48 pmRNSDirector/PDMR Shareholding
19th Sep 20234:35 pmRNSHolding(s) in Company
19th Sep 20234:30 pmRNSHolding(s) in Company
14th Sep 202310:21 amRNSHolding(s) in Company
12th Sep 20237:00 amRNSInterim Results
5th Sep 20235:26 pmRNSHolding(s) in Company
1st Sep 20237:00 amRNSTotal Voting Rights
11th Aug 202312:42 pmRNSDirector/PDMR Shareholding
4th Aug 20239:00 amRNSDirector/PDMR Shareholding
1st Aug 20233:12 pmRNSDirector Share Purchase
1st Aug 20239:57 amRNSTotal Voting Rights
1st Aug 20237:00 amRNSH1 Trading Update
28th Jul 20237:37 amRNSIssue of Shares
25th Jul 202310:42 amRNSHolding(s) in Company
21st Jul 20237:00 amRNSNew Revolving Credit Facility of $400 million
3rd Jul 202311:26 amRNSTotal Voting Rights
3rd Jul 202310:25 amRNSHolding(s) in Company
21st Jun 20237:00 amRNSAppointment of Chief Financial Officer
19th Jun 20232:59 pmRNSHolding(s) in Company
14th Jun 20237:00 amRNSExtension of EBT Market Purchases to EUR15 million
12th Jun 20237:16 amRNSIssue of Shares
9th Jun 20237:00 amRNSDirector Share Purchase
8th Jun 20232:42 pmRNSHolding(s) in Company
1st Jun 20233:53 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.